Salt Lake City, Utah (November 1, 2018) 4Life Transfer Factor® RioVida® Tri-Factor® Formula received 4Life’s sixth U.S. patent. Additionally, 4Life holds 38 international patents, with dozens more pending.
Chief Scientific Officer Dr. David Vollmer: “This patent covers the composition, manufacturing, and preservation of transfer factors in a liquid delivery format. It was constructed with over 30 unique and exclusive nutritional supplement claims, including the addition of various antioxidant fruit components currently represented in RioVida.”
Patents provide independent distributors with exclusivity, protection, and scientific credibility.
Founder and Chairman of the Board David Lisonbee: “Since 1998, 4Life has built upon its product innovation, exclusivity, and patent acquisition. Patents play a fundamental role in 4Life science and take years to procure. We invest heavily in their acquisition to protect the businesses of distributors for generations to come.”
4Life has offices in 24 markets to serve a global network of independent distributors and their customers.
For more information:
Vice President, Communications
4Life Research USA, LLC